Lucid Diligence Brief: Medtronic intent to acquire CathWorks
Lucid Diligence Brief: Medtronic intent to acquire CathWorks Professional…
Lucid Diligence Brief: Fortitude Biomedicines launch with $13M seed
Lucid Diligence Brief: Fortitude Biomedicines launch with $13M seed…
Lucid Diligence Brief: Neuralink’s 2026 high-volume BCI plan
Lucid Diligence Brief: Neuralink’s 2026 high-volume BCI plan Professional…
Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic
Lucid Diligence Brief: Vyriad $25M Series B to take in-vivo CAR-T into clinic…
Lucid Diligence Brief: Impulse Dynamics $158m financing
Lucid Diligence Brief: Impulse Dynamics $158m financing Professional audiences…
Lucid Diligence Brief: Paradigm to acquire Flatiron’s Clinical Research Business
Lucid Diligence Brief: Paradigm to acquire Flatiron’s Clinical Research…
Lucid Diligence Brief: Circular Genomics $15 million Series A for circular RNA biomarkers
Lucid Diligence Brief: Circular Genomics $15 million Series A for circular RNA…
Lucid Diligence Brief: WellBeam $10M Series A
Lucid Diligence Brief: WellBeam $10M Series A Professional audiences only. Not…
Lucid Diligence Brief: Abbott to acquire Exact Sciences
Lucid Diligence Brief: Abbott to acquire Exact Sciences Professional audiences…
Lucid Diligence Brief: Philips and Cortechs.ai quantitative neuroimaging partnership
Lucid Diligence Brief: Philips and Cortechs.ai quantitative neuroimaging…
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG platform
Lucid Diligence Brief: Beacon Biosignals $86M Series B to scale its AI-EEG…
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast
Lucid Diligence Brief: Clairity's $43 million Series B for Clairity Breast…